Suppr超能文献

跨越主要遗传屏障的造血干细胞移植:超大剂量CD34细胞和其他否决细胞诱导免疫耐受

Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.

作者信息

Reisner Yair, Gur Hilit, Reich-Zeliger Shlomit, Martelli Massimo F, Bachar-Lustig Esther

机构信息

Weizmann Institute of Science, Department of Immunology, Rehovot, Israel.

出版信息

Ann N Y Acad Sci. 2005 Jun;1044:70-83. doi: 10.1196/annals.1349.010.

Abstract

Studies in mice and humans demonstrate that transplantation of hematopoietic progenitors in numbers larger than commonly used overcomes major genetic barriers. In vitro studies suggest that veto cells, within the population of hematopoietic progenitors, facilitate this favorable outcome. Tolerance induction can be further enhanced by other veto cells. Perhaps the most potent veto cell is the CD8(+) CTL. However, this cell is also associated with marked GVHD, which can be separated from the veto activity by generating anti-third party CTLs under IL-2 deprivation.

摘要

对小鼠和人类的研究表明,移植数量超过常用量的造血祖细胞可克服主要的遗传障碍。体外研究表明,造血祖细胞群体中的否决细胞促成了这一有利结果。其他否决细胞可进一步增强耐受性诱导。也许最有效的否决细胞是CD8(+)CTL。然而,这种细胞也与明显的移植物抗宿主病有关,通过在白细胞介素-2缺乏的情况下产生抗第三方CTL,可将其与否决活性分离。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验